Compugen to Present New Research Enabling Accurate Detection of PVRIG
Compugen will present new research at AACR 2023 that allows for the accurate detection and study of novel target PVRIG.
Read moreCompugen will present new research at AACR 2023 that allows for the accurate detection and study of novel target PVRIG.
Read moreWith the 3-D Life Slow Gelling hydrogel kits, the set-up of 3D cell culture is easy. Growing cells in a
Read moreMachine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
Read moreChicago Headquartered Tempus, pioneering AI-enabled precision medicine, has entered a third strategic collaboration with pharma giant Pfizer, aiming to gather
Read moreTransCode Therapeutics and BRAIN Biotech have entered a joint research and development agreement (JDA) with the objective to co-develop a
Read moreThe GERBU Adjuvant P TM is developed specifically for polyclonal antibody production. Containing non-hazardous immuno active components, this adjuvant is
Read moreQIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, announced on Monday the launch of their enhanced QIAGEN CLC Genomics
Read moreModerna Inc will make investments in mRNA research and development (R&D) in the UK and construct a cutting-edge facility for
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe groundbreaking kit Clickable 19F NMR Probes, developed by CF Plus Chemicals, includes a variety of 9 fluorinated azides that
Read more